Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV‐2 infection

Abstract Anti‐inflammatory and immune‐modulatory therapies have been proposed for the treatment of COVID‐19 and its most serious complications. Among others, the use of mesenchymal stromal cells (MSCs) is under investigation given their well‐documented anti‐inflammatory and immunomodulatory properti...

Full description

Bibliographic Details
Main Authors: Maria A. Avanzini, Manuela Mura, Elena Percivalle, Francesca Bastaroli, Stefania Croce, Chiara Valsecchi, Elisa Lenta, Giulia Nykjaer, Irene Cassaniti, Jessica Bagnarino, Fausto Baldanti, Marco Zecca, Patrizia Comoli, Massimiliano Gnecchi
Format: Article
Language:English
Published: Oxford University Press 2021-04-01
Series:Stem Cells Translational Medicine
Subjects:
adult stem cells
angiotensin
cellular therapy
fetal stem cells
mesenchymal stromal cells (MSCs)
Online Access:https://doi.org/10.1002/sctm.20-0385

Internet

https://doi.org/10.1002/sctm.20-0385

Similar Items